Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
Dungan, Kathleen M, Dr, Povedano, Santiago Tofé, MD, Forst, Thomas, MD, González, José G González, Prof, Atisso, Charles, PhD, Sealls, Whitney, PhD, Fahrbach, Jessie L, MD
Published in The Lancet (British edition) (11.10.2014)
Published in The Lancet (British edition) (11.10.2014)
Get full text
Journal Article